Kolon Life Science Inc.
KOE: 102940.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Basic Materials
- Industry
- Chemicals
- CEO
- Seon-Jin Kim
- Employees
- 432
- Headquarters
- Seoul, South Korea
- IPO year
- 2009
- Market cap
- ₩792.6B
- Website
- https://www.kolonls.co.kr
Loading 102940…
Loading profile data…Frequently asked questions about 102940
What does Kolon Life Science Inc. (102940.KQ) do?
KOLON LIFE SCIENCE, Inc. engages in the manufacture and sale of pharmaceuticals and environmental materials. It operates through the Chemical and Bio business divisions. The Chemical business division refers to pharmaceutical business and specialty chemicals business. The Bio business division relates to biopharmaceutical contract development an...
Where does 102940.KQ trade?
Kolon Life Science Inc. (102940.KQ) trades on the KOSDAQ.
What sector is 102940.KQ in?
Kolon Life Science Inc. (102940.KQ) operates in the Basic Materials sector, specifically in the Chemicals industry.
Who is the CEO of Kolon Life Science Inc.?
Seon-Jin Kim is the chief executive officer of Kolon Life Science Inc. (102940.KQ).
Where is Kolon Life Science Inc. headquartered?
Kolon Life Science Inc. is headquartered in South Korea.
Does 102940.KQ pay a dividend?
Kolon Life Science Inc. (102940.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 102940.KQ go public?
Kolon Life Science Inc. (102940.KQ) completed its initial public offering in 2009.